Florian Willecke Selected Research

Purinergic P2Y2 Receptors

1/2016

Extracellular ATP Induces Vascular Inflammation and Atherosclerosis via Purinergic Receptor Y2 in Mice.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Florian Willecke Research Topics

Disease

12	Atherosclerosis 11/2021 - 04/2011
12	Inflammation (Inflammations) 10/2021 - 04/2011
6	Insulin Resistance 10/2018 - 01/2012
5	Obesity 10/2021 - 01/2012
4	Atherosclerotic Plaque (Atheroma) 11/2021 - 01/2015
4	Weight Gain 10/2021 - 01/2012
3	Hypercholesterolemia 11/2019 - 03/2016
2	Sepsis (Septicemia) 01/2018 - 01/2016
2	Peritonitis 01/2016 - 04/2011
1	Carotid Stenosis (Carotid Artery Stenosis) 12/2020
1	Infections 03/2020
1	Acute Coronary Syndrome 03/2020
1	Coronary Disease (Coronary Heart Disease) 03/2020
1	Neointima 01/2019
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 10/2018
1	Necrosis 01/2018
1	Neoplasms (Cancer) 01/2018
1	Bacteremia 01/2018
1	Cytokine Release Syndrome 01/2018
1	Heart Failure 01/2016
1	Hypertriglyceridemia 01/2015
1	Hyperglycemia 01/2015
1	Rupture 01/2013
1	Myocardial Infarction 01/2013
1	Metabolic Diseases (Metabolic Disease) 01/2012
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2012
1	Thrombosis (Thrombus) 11/2011
1	B-Cell Lymphoma (Lymphoma, B Cell) 09/2011
1	Asthma (Bronchial Asthma) 09/2011
1	Rheumatoid Arthritis 09/2011

Drug/Important Bio-Agent (IBA)

9	CholesterolIBA 12/2020 - 01/2015
5	Insulin (Novolin)FDA Link 10/2021 - 01/2012
5	LDL Receptors (LDL Receptor)IBA 01/2018 - 09/2011
3	Apolipoproteins E (ApoE)IBA 11/2021 - 03/2016
3	LipidsIBA 12/2020 - 01/2018
3	Glucose (Dextrose)FDA LinkGeneric 11/2019 - 06/2014
3	CD40 Ligand (CD40L)IBA 01/2019 - 11/2011
2	TNF Receptor-Associated Factor 5IBA 10/2021 - 01/2019
2	Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA 10/2021 - 01/2019
2	Factor V (Coagulation Factor V)IBA 10/2021 - 01/2019
2	Lipoproteins (Lipoprotein)IBA 12/2020 - 01/2018
2	OligonucleotidesIBA 11/2019 - 01/2018
2	Antisense OligonucleotidesIBA 11/2019 - 01/2018
2	LigandsIBA 01/2019 - 01/2018
2	Purinergic Receptors (Receptors, Purine)IBA 10/2018 - 01/2016
2	Adenosine Triphosphate (ATP)IBA 10/2018 - 01/2016
2	AdipokinesIBA 01/2018 - 01/2012
2	fostamatinibIBA 03/2016 - 09/2011
2	Fatty Acids (Saturated Fatty Acids)IBA 01/2016 - 01/2015
2	CytokinesIBA 01/2012 - 04/2011
1	ApolipoproteinsIBA 11/2021
1	Blood Glucose (Blood Sugar)IBA 10/2021
1	Atorvastatin (Lipitor)FDA Link 12/2020
1	LDL CholesterolIBA 12/2020
1	Lipoprotein(a)IBA 03/2020
1	oxidized low density lipoproteinIBA 03/2020
1	C-Reactive ProteinIBA 03/2020
1	Immunosuppressive Agents (Immunosuppressants)IBA 03/2020
1	Anti-Inflammatory Agents (Anti-Inflammatories)IBA 03/2020
1	empagliflozinIBA 11/2019
1	CollagenIBA 11/2019
1	C-PeptideIBA 10/2018
1	Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)IBA 10/2018
1	Purinergic P2 Receptors (ADP Receptor)IBA 10/2018
1	ChemokinesIBA 01/2018
1	Toll-Like Receptors (Toll-Like Receptor)IBA 01/2018
1	Therapeutic UsesIBA 01/2018
1	Messenger RNA (mRNA)IBA 01/2018
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2018
1	IntegrinsIBA 01/2018
1	InflammasomesIBA 06/2017
1	Purinergic P2Y2 ReceptorsIBA 01/2016
1	PalmitatesIBA 01/2015
1	Triglycerides (Triacylglycerol)IBA 01/2015
1	FGK45 monoclonal antibodyIBA 06/2014
1	Fibrin Tissue Adhesive (Fibrin Sealant)IBA 01/2013
1	Immunoglobulin G (IgG)IBA 01/2012
1	AntibodiesIBA 01/2012
1	Peptides (Polypeptides)IBA 11/2011
1	Syk KinaseIBA 09/2011
1	1,1-dimethylbutyl-1-deoxy-Delta(9)-THCIBA 04/2011
1	Cannabinoid Receptors (Cannabinoid Receptor)IBA 04/2011

Therapy/Procedure

2	Therapeutics 03/2020 - 01/2018
2	Fat-Restricted Diet (Diet, Fat Restricted) 01/2015 - 01/2012
1	Diet Therapy (Therapy, Diet) 12/2020
1	Drug Therapy (Chemotherapy) 03/2020